157 related articles for article (PubMed ID: 37651362)
1. Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway.
Qi Y; Wu H; Zhu T; Liu Z; Liu C; Yan C; Wu Z; Xu Y; Bai Y; Yang L; Cheng D; Zhang X; Zhao H; Zhao C; Dai X
Aging (Albany NY); 2023 Aug; 15(16):8258-8274. PubMed ID: 37651362
[TBL] [Abstract][Full Text] [Related]
2. Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition.
Bai Y; Wang X; Cai M; Ma C; Xiang Y; Hu W; Zhou B; Zhao C; Dai X; Li X; Zhao H
Am J Cancer Res; 2021; 11(1):200-214. PubMed ID: 33520369
[TBL] [Abstract][Full Text] [Related]
3. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
[TBL] [Abstract][Full Text] [Related]
4. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis.
Park SJ; Jung HJ
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
[TBL] [Abstract][Full Text] [Related]
5. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
6. β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis.
Wu Z; Wu H; Wang Z; Li H; Gu H; Xia E; Yan C; Dai Y; Liu C; Wang X; Lv L; Bao J; Wang O; Dai X
Phytomedicine; 2023 Jun; 114():154769. PubMed ID: 36940580
[TBL] [Abstract][Full Text] [Related]
7. Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling.
Yan S; Ma C; Zhou F; Zheng H; Yang L; Xiao Z; Zhu J; Zhao H; Zhao C; Xu X
J Cancer; 2023; 14(17):3309-3320. PubMed ID: 37928418
[No Abstract] [Full Text] [Related]
8. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH
Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924
[TBL] [Abstract][Full Text] [Related]
9. A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction.
Park SK; Byun WS; Lee S; Han YT; Jeong YS; Jang K; Chung SJ; Lee J; Suh YG; Lee SK
Biochem Pharmacol; 2020 Aug; 178():114053. PubMed ID: 32450253
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
Yang L; Zhou F; Zhuang Y; Liu Y; Xu L; Zhao H; Xiang Y; Dai X; Liu Z; Huang X; Wang L; Zhao C
Br J Cancer; 2021 Feb; 124(3):645-657. PubMed ID: 33122847
[TBL] [Abstract][Full Text] [Related]
11. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3.
Zhu Z; Yuan J; Xu X; Wei Y; Yang B; Zhao H
Neoplasia; 2021 Jan; 23(1):36-48. PubMed ID: 33217668
[TBL] [Abstract][Full Text] [Related]
12. Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
Liu CY; Chen KF; Chao TI; Chu PY; Huang CT; Huang TT; Yang HP; Wang WL; Lee CH; Lau KY; Tsai WC; Su JC; Wu CY; Chen MH; Shiau CW; Tseng LM
J Mol Med (Berl); 2017 Sep; 95(9):965-975. PubMed ID: 28578456
[TBL] [Abstract][Full Text] [Related]
13. Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling.
Liu H; Yan R; Xiao Z; Huang X; Yao J; Liu J; An G; Ge Y
Breast Cancer Res; 2023 Apr; 25(1):43. PubMed ID: 37069669
[TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
Tian J; Chen X; Fu S; Zhang R; Pan L; Cao Y; Wu X; Xiao H; Lin HJ; Lo HW; Zhang Y; Lin J
Breast Cancer Res Treat; 2019 Jun; 175(3):553-566. PubMed ID: 30852762
[TBL] [Abstract][Full Text] [Related]
15. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
17. STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer
Liao PA; Chu PY; Tan ZL; Hsu FT; Lee YC; Wu HJ
Anticancer Res; 2022 Aug; 42(8):3807-3814. PubMed ID: 35896246
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.
Dees S; Pontiggia L; Jasmin JF; Mercier I
Cancer Biol Ther; 2020 Jun; 21(6):506-521. PubMed ID: 32164483
[TBL] [Abstract][Full Text] [Related]
19. Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia-inducible factor 1α axis.
Li X; Chen C; Dai Y; Huang C; Han Q; Jing L; Ma Y; Xu Y; Liu Y; Zhao L; Wang J; Sun X; Yao X
Cancer Sci; 2019 May; 110(5):1724-1734. PubMed ID: 30839155
[TBL] [Abstract][Full Text] [Related]
20. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]